Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Champions Oncology (CSBR) FCF Margin (2016 - 2026)

Champions Oncology (CSBR) has 16 years of FCF Margin data on record, last reported at 11.39% in Q4 2025.

  • For Q4 2025, FCF Margin fell 929.0% year-over-year to 11.39%; the TTM value through Oct 2025 reached 9.95%, up 1360.0%, while the annual FY2025 figure was 12.29%, 2452.0% up from the prior year.
  • FCF Margin reached 11.39% in Q4 2025 per CSBR's latest filing, down from 3.96% in the prior quarter.
  • Across five years, FCF Margin topped out at 55.9% in Q2 2025 and bottomed at 37.09% in Q3 2023.
  • Average FCF Margin over 5 years is 0.34%, with a median of 0.87% recorded in 2024.
  • Peak YoY movement for FCF Margin: crashed -3846bps in 2021, then skyrocketed 6288bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 5.62% in 2021, then skyrocketed by 234bps to 18.78% in 2022, then plummeted by -77bps to 4.41% in 2023, then plummeted by -148bps to 2.1% in 2024, then crashed by -443bps to 11.39% in 2025.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 11.39% in Q4 2025, 3.96% in Q3 2025, and 55.9% in Q2 2025.